Karyofyllis, Panagiotis https://orcid.org/0000-0002-0717-8544
Tsiapras, Dimitrios
Demerouti, Eftychia
Armenis, Iakovos
Papadopoulou, Varvara
Voudris, Vassilis
Article History
Accepted: 18 May 2021
First Online: 27 May 2021
Declarations
:
: Panagiotis Karyofyllis has received lecture fees from Actelion Pharmaceuticals Hellas, Bayer Hellas, and GlaxoSmithKline. Eftychia Demerouti has received lecture fees from Actelion Pharmaceuticals Hellas, Bayer Hellas, GlaxoSmithKline and MSD Hellas. All other authors declare that they have no conflict of interest.
: The patient has given written informed consent to publish the case.